Your browser doesn't support javascript.
loading
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
Painter, Jodie N; O'Mara, Tracy A; Morris, Andrew P; Cheng, Timothy H T; Gorman, Maggie; Martin, Lynn; Hodson, Shirley; Jones, Angela; Martin, Nicholas G; Gordon, Scott; Henders, Anjali K; Attia, John; McEvoy, Mark; Holliday, Elizabeth G; Scott, Rodney J; Webb, Penelope M; Fasching, Peter A; Beckmann, Matthias W; Ekici, Arif B; Hein, Alexander; Rübner, Matthias; Hall, Per; Czene, Kamila; Dörk, Thilo; Dürst, Matthias; Hillemanns, Peter; Runnebaum, Ingo; Lambrechts, Diether; Amant, Frederic; Annibali, Daniela; Depreeuw, Jeroen; Vanderstichele, Adriaan; Goode, Ellen L; Cunningham, Julie M; Dowdy, Sean C; Winham, Stacey J; Trovik, Jone; Hoivik, Erling; Werner, Henrica M J; Krakstad, Camilla; Ashton, Katie; Otton, Geoffrey; Proietto, Tony; Tham, Emma; Mints, Miriam; Ahmed, Shahana; Healey, Catherine S; Shah, Mitul; Pharoah, Paul D P; Dunning, Alison M.
Afiliação
  • Painter JN; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • O'Mara TA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Morris AP; Wellcome Trust for Human Genetics, University of Oxford, Oxford, UK.
  • Cheng THT; Department of Biostatistics, University of Liverpool, Liverpool, UK.
  • Gorman M; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Martin L; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Hodson S; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Jones A; Department of Clinical Genetics, St George's, University of London, London, UK.
  • Martin NG; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Gordon S; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Henders AK; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Attia J; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
  • McEvoy M; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Holliday EG; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Scott RJ; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Webb PM; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Fasching PA; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Beckmann MW; Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Ekici AB; Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Hein A; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Rübner M; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Hall P; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California.
  • Czene K; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Dörk T; Institute of Human Genetics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Dürst M; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Hillemanns P; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Runnebaum I; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Lambrechts D; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Amant F; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Annibali D; Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
  • Depreeuw J; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Vanderstichele A; Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
  • Goode EL; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Cunningham JM; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Dowdy SC; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Winham SJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Trovik J; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Hoivik E; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Werner HMJ; Vesalius Research Center, VIB, Leuven, Belgium.
  • Krakstad C; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
  • Ashton K; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Otton G; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Proietto T; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, Minnesota.
  • Tham E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Mints M; Centre for Cancerbiomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Ahmed S; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
  • Healey CS; Centre for Cancerbiomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Shah M; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
  • Pharoah PDP; Centre for Cancerbiomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Dunning AM; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Cancer Med ; 7(5): 1978-1987, 2018 05.
Article em En | MEDLINE | ID: mdl-29608257
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Predisposição Genética para Doença / Endometriose / Proteínas Tirosina Fosfatases Classe 2 Semelhantes a Receptores Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans País/Região como assunto: Oceania Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Predisposição Genética para Doença / Endometriose / Proteínas Tirosina Fosfatases Classe 2 Semelhantes a Receptores Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans País/Região como assunto: Oceania Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália